H.R. 810 was passed to the Senate for consideration on May 26, 2005. After being stalled in the Republican-led Senate for more than a year, the Senate passed it on July 18, 2006 by a bipartisan vote of 63 to 37.
President George W. Bush vetoed the bill on July 19, 2006, citing ideological grounds supported by the religious right.
H.R. 810 would have permitted federal funding for embryonic stem cell research on cells "derived from human embryos that have been donated from in vitro fertilization clinics, were created for the purposes of fertility treatment, and were in excess of the clinical need of the individuals seeking such treatment."
The following is the complete text of H.R. 810 that will voted upon by the Senate:
Stem Cell Research Enhancement Act of 2005
HR 810 RDS
H. R. 810
IN THE SENATE OF THE UNITED STATES
May 26, 2005
Received and read the first time
To amend the Public Health Service Act to provide for human embryonic stem cell research.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the Stem Cell Research Enhancement Act of 2005'.
SEC. 2. HUMAN EMBRYONIC STEM CELL RESEARCH.
Part H of title IV of the Public Health Service Act (42 U.S.C. 289 et seq.) is amended by inserting after section 498C the following:
SEC. 498D. HUMAN EMBRYONIC STEM CELL RESEARCH.
(a) In General- Notwithstanding any other provision of law (including any regulation or guidance), the Secretary shall conduct and support research that utilizes human embryonic stem cells in accordance with this section (regardless of the date on which the stem cells were derived from a human embryo).
(b) Ethical Requirements- Human embryonic stem cells shall be eligible for use in any research conducted or supported by the Secretary if the cells meet each of the following:
(1) The stem cells were derived from human embryos that have been donated from in vitro fertilization clinics, were created for the purposes of fertility treatment, and were in excess of the clinical need of the individuals seeking such treatment.
(2) Prior to the consideration of embryo donation and through consultation with the individuals seeking fertility treatment, it was determined that the embryos would never be implanted in a woman and would otherwise be discarded.
(3) The individuals seeking fertility treatment donated the embryos with written informed consent and without receiving any financial or other inducements to make the donation.
(c) Guidelines- Not later than 60 days after the date of the enactment of this section, the Secretary, in consultation with the Director of NIH, shall issue final guidelines to carry out this section.
(d) Reporting Requirements- The Secretary shall annually prepare and submit to the appropriate committees of the Congress a report describing the activities carried out under this section during the preceding fiscal year, and including a description of whether and to what extent research under subsection (a) has been conducted in accordance with this section.
Passed the House of Representatives May 24, 2005.